doxofylline has been researched along with Pulmonary Disease, Chronic Obstructive in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 7 (38.89) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Du, X; Zhao, D | 1 |
| Chen, ZY; Chu, SQ; Li, Y; Lin, YM; Wu, JH; Xie, WX; Zhang, XQ; Zhang, Y | 1 |
| Canakci, ME; Sevik, OE | 1 |
| Ge, G; Ma, H; Mao, M; Pan, Q; Qian, X; Song, P; Wang, H; Xia, S; Yang, L; Zhao, X; Zou, L | 1 |
| Cazzola, M; Matera, MG | 1 |
| Wang, Y | 1 |
| Chen, ZY; Gao, XH; Huang, CL; Lin, AM; Liu, CY; Wu, JH; Xu, XT; Zhang, Y | 1 |
| Quanqing, M | 1 |
| Cazzola, M; Matera, MG; Page, C | 1 |
| Calzetta, L; Cazzola, M; Matera, MG; Page, C; Rogliani, P | 1 |
| Barnes, PJ; Calzetta, L; Cazzola, M; Criner, GJ; Gabriella Matera, M; Martinez, FJ; Papi, A | 1 |
| Kumar, R; Lal, D; Manocha, S; Ray, A; Vijayan, VK | 1 |
| Santra, CK | 1 |
| Chakraborty, S; Mishra, B; Shukla, D; Singh, S | 1 |
| Hu, Y; Li, C; Li, F; Liu, X; Luo, G; Ma, J; Sun, J; Wang, J; Wang, T; Xiong, S; Xiong, W; Xu, Y; Zhang, Z; Zhao, J; Zhao, S; Zuo, P | 1 |
| Chakraborty, S; Mishra, B; Shukla, D | 1 |
| Barr, RG; Camargo, CA; Rowe, BH | 2 |
7 review(s) available for doxofylline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
The effect of doxofylline in asthma and COPD.
Topics: Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Drug Costs; Economics, Pharmaceutical; Female; Humans; Male; Pulmonary Disease, Chronic Obstructive; Theophylline; Treatment Outcome | 2020 |
Doxofylline is not just another theophylline!
Topics: Animals; Asthma; Bronchodilator Agents; Disease Progression; Drug Interactions; Hospitalization; Humans; Lung; Pulmonary Disease, Chronic Obstructive; Risk Factors; Theophylline; Treatment Outcome | 2017 |
Impact of doxofylline in COPD: A pairwise meta-analysis.
Topics: Bronchodilator Agents; Forced Expiratory Volume; Humans; Pulmonary Disease, Chronic Obstructive; Theophylline; Treatment Outcome | 2018 |
Efficacy and safety profile of xanthines in COPD: a network meta-analysis.
Topics: Bronchodilator Agents; Forced Expiratory Volume; Humans; Lung; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Theophylline; Treatment Outcome; Xanthines | 2018 |
Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Databases, Bibliographic; Humans; Pulmonary Disease, Chronic Obstructive; Theophylline; Treatment Outcome | 2009 |
Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials.
Topics: Administration, Oral; Aminophylline; Bronchodilator Agents; Forced Expiratory Volume; Humans; Infusions, Intravenous; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Theophylline; Treatment Outcome | 2003 |
Methyl-xanthines for exacerbations of chronic obstructive pulmonary disease.
Topics: Aminophylline; Bronchodilator Agents; Humans; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Theophylline | 2001 |
5 trial(s) available for doxofylline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy and safety of combined doxofylline and salbutamol in treatment of acute exacerbation of chronic obstructive pulmonary disease.
Topics: Albuterol; Humans; Lung; Pulmonary Disease, Chronic Obstructive; Theophylline | 2021 |
Theophylline Acetaldehyde as the Initial Product in Doxophylline Metabolism in Human Liver.
Topics: Acetaldehyde; Adult; Animals; Asthma; Bronchodilator Agents; Cytochrome P-450 Enzyme System; Female; Healthy Volunteers; Humans; Liver; Macaca fascicularis; Mice; Microsomes, Liver; Oxidation-Reduction; Pulmonary Disease, Chronic Obstructive; Rabbits; Rats; Theophylline | 2020 |
The study of long term curative effect of chronic obstructive pulmonary disease in remission stage treated with TCM.
Topics: Acupressure; Acupuncture Therapy; Aged; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Oxygen; Pulmonary Disease, Chronic Obstructive; Qigong; Respiratory Function Tests; Theophylline | 2017 |
Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
Topics: Adult; Aged; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Spirometry; Theophylline; Treatment Outcome | 2008 |
Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Bronchodilator Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Scopolamine Derivatives; Theophylline; Tiotropium Bromide | 2011 |
6 other study(ies) available for doxofylline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Effect of doxofylline on pulmonary inflammatory response and oxidative stress during mechanical ventilation in rats with COPD.
Topics: Animals; Disease Models, Animal; Inflammation; Interleukin-10; Male; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Random Allocation; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Theophylline; Tumor Necrosis Factor-alpha | 2022 |
Doxofylline in acute exacerbation of chronic obstructive pulmonary disease.
Topics: Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; Theophylline | 2022 |
Effects of Doxofylline Combined with Ceftazidime on Clinical Efficacy, Drug Safety, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease Complicated with Infection.
Topics: Aged; Ceftazidime; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infections; Lung; Male; Middle Aged; Prognosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Theophylline; Treatment Outcome | 2021 |
Effect of Doxofylline on Reducing the Inflammatory Response in Mechanically Ventilated Rats with Chronic Obstructive Pulmonary Disease.
Topics: Animals; Lung; Male; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Theophylline; Tumor Necrosis Factor-alpha | 2021 |
Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease.
Topics: Adult; Asthma; Bronchodilator Agents; Female; Humans; Male; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Theophylline | 2015 |
Evaluation of in vivo behavior of controlled and pulsatile release pastilles using pharmacokinetic and γ-scintigraphic techniques.
Topics: Administration, Oral; Animals; Asthma; Biological Availability; Bronchodilator Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Gastrointestinal Tract; Gastrointestinal Transit; Intestinal Mucosa; Male; Pharmaceutical Preparations; Pulmonary Disease, Chronic Obstructive; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tablets; Tablets, Enteric-Coated; Technetium Tc 99m Pentetate; Theophylline | 2012 |